These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23780501)

  • 1. Formulation and pharmacokinetics of ketorolac tromethamine fast dissolving tablets.
    Mettu SR; Veerareddy PR
    Drug Res (Stuttg); 2013 Nov; 63(11):586-90. PubMed ID: 23780501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
    Gordon MS; Chowhan Z
    Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, evaluation and pharmacokinetics of time-dependent ketorolac tromethamine tablets.
    Vemula SK; Veerareddy PR
    Expert Opin Drug Deliv; 2013 Jan; 10(1):33-45. PubMed ID: 23199134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and pharmacokinetics of colon-specific double-compression coated mini-tablets: Chronopharmaceutical delivery of ketorolac tromethamine.
    Vemula SK
    Int J Pharm; 2015 Aug; 491(1-2):35-41. PubMed ID: 26056929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and in vitro evaluation of controlled release hydrophilic matrix tablets of ketorolac tromethamine using factorial design.
    Genç L; Jalvand E
    Drug Dev Ind Pharm; 2008 Aug; 34(8):903-10. PubMed ID: 18686094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen.
    Daravath B; Tadikonda RR; Vemula SK
    Drug Dev Ind Pharm; 2015; 41(8):1254-62. PubMed ID: 25039470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro-in vivo characterization of release modifying agents for parenteral sustained-release ketorolac formulation.
    Puri V; Bansal AK
    Drug Dev Ind Pharm; 2004 Jul; 30(6):619-26. PubMed ID: 15285335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intranasal ketorolac tromethamine pharmacokinetics in younger and older adults.
    Bullingham R; Juan A
    Drugs Aging; 2012 Nov; 29(11):899-904. PubMed ID: 23143939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality by design (QbD) approach to develop fast-dissolving tablets using melt-dispersion paired with surface-adsorption method: formulation and pharmacokinetics of flurbiprofen melt-dispersion granules.
    Drug Deliv Transl Res; ; . PubMed ID: 37458973
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.